Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KRYS | CYTK | RGEN | ||
| Company | Krystal Biotech Inc | Cytokinetics | Repligen Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 275.17 | 66.43 | 134.08 | ||
| High | 278.06 | 66.49 | 134.94 | ||
| Low | 271.31 | 64.99 | 124.02 | ||
| Latest | 276.36 | 66.31 | 125.08 | ||
| Change | +3.70 | +0.51 | -7.62 | ||
| % Change | +1.36% | +0.78% | -5.74% | ||
| Volume | 233,144 | 734,926 | 746,265 | ||
| 20-Day Average Volume | 261,709 | 1,614,610 | 855,272 | ||
| Previous Close | 272.66 | 65.80 | 132.70 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 262.60 | 65.25 | 121.51 | ||
| 20-Day Raw Stochastic | 88.00% | 70.35% | 49.57% | ||
| 20-Day Relative Strength | 57.03 | 54.38 | 49.57 | ||
| Weighted Alpha | +75.13 | +36.07 | -14.02 | ||
| Today's Opinion | 88% Buy | 100% Buy | 40% Sell | ||
| Previous Opinion | 88% Buy | 100% Buy | 40% Sell | ||
| Last Month's Opinion | 40% Buy | 8% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.20% since 04/15/26 | +1.21% since 04/15/26 | -4.93% since 04/15/26 | ||
| Low | 262.02 on 04/16/26 | 63.97 on 04/16/26 | 124.55 on 04/22/26 | ||
| High | 278.86 on 04/20/26 | 67.04 on 04/17/26 | 141.46 on 04/21/26 | ||
| 1-Month | |||||
| %Chg | +9.04% since 03/20/26 | +7.23% since 03/20/26 | +10.13% since 03/20/26 | ||
| Low | 242.00 on 03/31/26 | 59.03 on 03/24/26 | 109.66 on 03/27/26 | ||
| High | 278.86 on 04/20/26 | 68.71 on 04/02/26 | 141.46 on 04/21/26 | ||
| 3-Month | |||||
| %Chg | -5.08% since 01/22/26 | +1.89% since 01/22/26 | -25.31% since 01/22/26 | ||
| Low | 242.00 on 03/31/26 | 58.43 on 03/13/26 | 109.66 on 03/27/26 | ||
| High | 298.30 on 02/17/26 | 70.39 on 02/24/26 | 169.78 on 01/23/26 | ||
| 6-Month | |||||
| %Chg | +47.21% since 10/22/25 | +20.82% since 10/22/25 | -20.32% since 10/22/25 | ||
| Low | 183.03 on 10/23/25 | 54.30 on 10/23/25 | 109.66 on 03/27/26 | ||
| High | 298.30 on 02/17/26 | 70.98 on 12/22/25 | 175.77 on 01/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,026,020 | 8,104,126 | 7,484,146 | ||
| Shares Outstanding, K | 29,436 | 123,163 | 56,399 | ||
| Annual Sales | 389,130,000 | 88,040,000 | 738,260,000 | ||
| Annual Net Income | 204,830,000 | -784,960,000 | 48,890,000 | ||
| Last Quarter Sales | 107,110,000 | 17,760,000 | 197,910,000 | ||
| Last Quarter Net Income | 51,400,000 | -183,030,000 | 13,290,000 | ||
| 60-Month Beta | 0.54 | 0.47 | 1.19 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.70 on 02/17/26 | -1.50 on 02/24/26 | 0.49 on 02/24/26 | ||
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 40.37 | 0.00 | 77.19 | ||